Skip to content

Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice.

Vítor Bruno, Lídia Emmanuela Wiazowski Spelta, Matheus Lujan Pereira, Fabiane Dörr, Beatriz Aparecida Passos Bismara Paranhos, Fabiana Pereira Santos, Mauricio Yonamine, Raphael Caio Tamborelli Garcia, Larissa Helena Torres, Roberto De Pasquale, Rosana Camarini, Tânia Marcourakis

Psychopharmacology October 31, 2025 DOI: 10.1007/s00213-025-06946-0 via PubMed

Summary

AI-generated from the abstract

Ayahuasca, a brew containing DMT and β-carbolines used in indigenous rituals, has shown potential for treating substance use disorders. In C57Bl/6 mice, ayahuasca at a high dose (15 mg DMT/kg) induced rewarding effects, but these were weaker than those of cocaine. When mice were conditioned with cocaine and later treated with ayahuasca (12.5 or 15 mg DMT/kg), the brew prevented the reinstatement of cocaine-induced conditioned place preference after a cocaine challenge. The findings suggest ayahuasca may have therapeutic value for cocaine use disorder by reducing relapse to drug-seeking behavior.

Study at a glance

Characteristics Experimental study Peer reviewed
Population C57Bl/6 mice
Topics Addiction Ayahuasca
Keywords Cocaine use disorder Conditioned place preference Psychedelics
Key finding Ayahuasca treatment prevented the reinstatement of cocaine-induced conditioned place preference in mice.

Abstract

Ayahuasca is a brew containing the psychedelic compound N,N-dimethyltryptamine (DMT) and β-carbolines, traditionally consumed in indigenous rituals. Recent studies suggest its potential to reduce depression and anxiety and as an alternative for treating ethanol and tobacco use disorders. However, research on its impact on cocaine use disorder remains limited. To analyze the rewarding effects of ayahuasca and to evaluate its therapeutic application on the reinstatement of cocaine-induced conditioned place preference (CPP) in C57Bl/6 mice. First, we examined if ayahuasca (2.5, 7.5, 12.5 and 15 mg DMT/kg, gavage) could induce CPP. Next, using a choice-based CPP paradigm, we compared the rewarding effects of cocaine (10 mg/kg, i.p.) with a previously established rewarding dose of ayahuasca (15 mg DMT/kg). Finally, we employed a cocaine-induced reinstatement protocol to assess whether ayahuasca could prevent the reactivation of cocaine-associated contextual preference. Therefore, mice were conditioned with cocaine and subsequently treated with water or ayahuasca (12.5 or 15 mg DMT/kg). Following a cocaine challenge, reinstatement of cocaine-induced CPP was evaluated. Our findings showed that while ayahuasca induced rewarding effects with the higher dose tested, these were less pronounced than those of cocaine. Moreover, ayahuasca treatment effectively prevented the cocaine-induced CPP reinstatement. These findings support the therapeutic potential of ayahuasca in the context of cocaine use disorder.

Explore topics

Comments

No comments yet.

Log in to comment